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STUDY PROTOCOL Open Access
Evaluation of aWeb-based tailored intervention
(TAVIE en santé) to support people livingwithHIV
in the adoption of health promotingbehaviours:
an online randomized controlled trial protocol
José Côté1,2,3*, Sylvie Cossette3,4, Pilar Ramirez-Garcia3, Alexandra De Pokomandy5, Catherine Worthington6,
Marie-Pierre Gagnon7,8, Patricia Auger1,2, François Boudreau9, Joyal Miranda10, Yann-Gaël Guéhéneuc11,12
and Cécile Tremblay1,13,14
Abstract
Background: Long-term use of antiretroviral therapy, normal aging, and presence of certain risk factors are
associated with metabolic disorders that predispose persons living with HIV to diabetes and cardiovascular
diseases. The emergence and progression of these disorders can be prevented by adopting healthy behaviours. Based
on the theory of planned behaviour, the Web-based tailored intervention TAVIE en santé was developed. The aim of
this study is to evaluate the effectiveness of TAVIE en santé in order to support people living with HIV in the adoption
of health promoting behaviours.
Methods/Design: An online randomized controlled trial with parallel-groups will be conducted across Canada.
To participate in this study, people living with HIV must be: ≥ 18 years, able to read/understand French or
English, have access to the Internet. A convenience sample of 750 participants will be randomly assigned
either to an experimental group (TAVIE en santé, n = 375) or to a control group (websites, n = 375) (1:1 allocation ratio).
The TAVIE en santé intervention is composed of seven interactive computer sessions, lasting between 5 and 10 min.
The sessions, hosted by a virtual nurse, aim to develop and strengthen skills required for behaviour change. The control
group will receive a validated list of five predetermined conventional health-related Websites. The adoption of health
behaviour (smoking cessation or physical activity or healthy eating) is the principal outcome. Cognitions (intention,
attitude, perceived behavioral control) are the secondary outcomes. Health indicators will also be assessed. All
outcomes will be measured with a self-administered online questionnaire and collected three times: at baseline, 3 and
6 months after. The principal analyses will focus on differences between the two trial groups using Intention-to-Treat
analysis.
Discussion: This study will yield new results about the efficacy of Web-based tailored health behaviours
change interventions in the context of chronic disease. The TAVIE en santé intervention could constitute an
accessible complementary service in support of existing specialized services to support people living with HIV
adopt health behaviors.
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Background
The advent of powerful antiretroviral therapy (ART)
has contributed to a substantial reduction in morbid-
ity and mortality among persons living with HIV
(PLHIV). Formerly considered a terminal illness, HIV
infection is now considered as a chronic disease [1–4]
and new HIV-associated complications are increas-
ingly emerging [3]. For instance, the occurence of
metabolic disorders, including glucose metabolism
dysfunction, dyslipidemia and cardiovascular diseases
have been found to be associated with the long-term
use of ART, the normal aging process, and the pres-
ence of certain risk factors [5–9]. Notably, compared
to the general population, smoking is more prevalent
[10–14] and physical activity levels are lower among
PLHIV [15, 16]. Also, PLHIV are likely to exceed the
guidelines for recommended saturated fat [17, 18] and
cholesterol dietary intake [19]. Thus, to prevent the
emergence and progression of comorbid problems,
such as diabetes and cardiovascular diseases, it is essen-
tial to intervene actively on modifiable risk factors in
order to help PLHIV adopt health promoting behav-
iours [20].
In the domain of health behaviour change interven-
tions, the deployment and utilisation of information and
communications technologies (ICT) as a way to deliver
the interventions appear to be promising and has the
potential to promote healthy behaviours [21, 22]. In their
meta-analysis of Web-delivered tailored health behaviour
change interventions (n = 40 randomized controlled tri-
als), Lustria and colleagues (2013) reported that tai-
lored, Web-based interventions had a significantly
greater effect on healthy behaviours, such as smoking
cessation, physical activity, healthy eating, than the
comparison/control conditions (e.g., a non-tailored or
waitlist control condition) [21]. However, web-based
tailored interventions have been most successful when
targeting general populations (n = 26, d = 0.181, 95 %
confidence interval (CI) 0.148–0.214) rather than cho-
nically ill patients (n = 6, d = 0.140, 95 % CI 0.037–
0.244). Until recently, preventing comorbidities among
PLHIV has involved more traditional interventions
addressing mostly smoking cessation [13, 14], to pro-
mote and/or increase physical activity [23, 24] and to
improve diet [25]. However, ICT has allowed diversifi-
cation in the modalities and kinds of interventions
available to support this population in the management
of the demands inherent to their health condition. Ac-
cording to two literature reviews [26, 27], ICT-
supported interventions aimed at PLHIV have shown
promising results. However, until now their deploy-
ments and utilisations have been focused on adher-
ence to HIV treatments.
Given the need to intervene actively on the modifi-
able risk factors in order to prevent the emergence
and progression of comorbid problems among PLHIV
and the advances in health behavior change interven-
tions using ICT, we have developed a Web-based tai-
lored intervention called TAVIE en santé. Its aims to
support PLHIV in the adoption of health promoting
behaviors such as ceasing smoking, engaging in phys-
ical activity, and following healthy eating habits.
Prior work: TAVIE™ Web platform
In our previous work, we developed a virtual inter-
vention concept called TAVIE (Your life) (French
acronym for Traitement Assistance Virtuelle Infirmière
et Enseignement or Treatment Virtual Nurse Assist-
ance and Teaching) along with an innovative Web
platform. Based on theories of behaviour change,
TAVIE™ targets the development and consolidation of
skills in order to enhance an individual’s ability to
act. The aim is to provide individuals with real-time
tailored support in managing the challenges inherent
to their health conditions. The Web-based interven-
tions developed on the TAVIE™ platform are unique in
their tailored design that adapts content to users’ pro-
files and needs, the scientific rigour of the content and
flexibility of use.
Theoretical framework of TAVIE en santé
The theory of planned behavior (TPB) by Ajzen [28]
has been used to predict and explain many health be-
haviors [29]. Based on the TPB, the adoption of a be-
havior is determined principally by the participant’s
intention; however when adopting the behavior is not
completely under volitional control, it is necessary to
consider perceived behavior control. Perceived behav-
ioral control, attitudes and subjective norms also play
a role in behavior adoption, primarily through their
effect on intention. External variables such as individ-
ual and environmental characteristics also influence
these determinants. TPB as a guide in the develop-
ment of the TAVIE en santé intervention, whose aim
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is to support PLHIV in quitting smoking, to practice
physical activity and eating healthy foods. The follow-
ing determinants of TPB are targeted to change par-
ticipants’ behaviours: intention, attitude and perceived
behavioural control.
Study objective and hypotheses
This study aims to evaluate the effectiveness of a
Web-based tailored intervention, TAVIE en santé, in
supporting PLHIV to adopt health promoting behav-
iours, such as smoking cessation, being physically ac-
tive and eating healthy.
The primary hypothesis is that at the 6-month
follow-up, a significantly higher proportion of experi-
mental group (EG) participants will have succeeded in
changing the specific health behaviour that they indi-
vidually selected (smoking cessation being physically
active or healthy eating) when compared with the con-
trol group (CG) participants. The secondary hypothesis
is that at the 3-month follow-up, compared with CG
participants, EG participants will show significantly
higher scores on intention, attitude, and perceived con-
trol regarding the adoption of their chosen health
behaviour.
Methods/Design
Study design
An online randomized, controlled parallel-group trial will
be conducted to evaluate the effectiveness of the Web-
based tailored intervention TAVIE en santé. A conveni-
ence sample of participants will be randomly assigned
either to an experimental group (TAVIE en santé) or to a
control group (list of various Websites). Randomization
will be performed as block randomization with a 1:1 allo-
cation. Health behaviours, such as smoking cessation,
being physically active and healthy eating are the pri-
mary outcomes. Cognitions (intention, attitude, and
perceived behavioural control) towards the behaviour
constitute the secondary outcomes.
Population, study setting and sample size
The target population for this study is composed of
Canadian PLHIV. According to the Public Health
Agency of Canada (PHAC) [30], there were approxi-
mately 78,500 PLHIV living in Canada in 2013. On-
tario accounted for the highest proportion of new
reported PLHIV (39.6 % of reported positive HIV
tests), followed by Quebec (21.7 %), and British
Columbia (13.0 %). Thus, recruitment for this study
will take place mainly in medical clinics and community
organizations working with PLHIV in Ontario, Quebec,
and British Columbia.
To participate, PLHIV must: 1) be 18 years of age or
older; 2) be able to read and understand French or Eng-
lish; and 3) have access to the Internet.
To achieve the study’s objective, 375 participants per
group are needed, for a total sample of 750 participants.
This sample size was estimated to ensure 80 % statistical
power for a 2-tailed chi-square test, at a significance
level of α = 0.05, to detect any difference equal to or
higher than about 10 % between the failure rates (failure
to change the chosen behaviour-binary outcome) esti-
mated in ITT analyses for the two randomization
groups. This calculation takes into account the two likely
limitations of the study: possible misclassification of self-
reported outcomes and attrition. Similar to other online
trials (Schubart review’s [31]: 15 trials reported less than
20 % of attrition), we expect up to 20 % attrition during
the 6 months of follow-up.
Interventions
During an individualized targeted online assessment,
participants will have to choose a health behavior they
wish to adopt (smoking cessation or increasing physical
activity or adopting healthy eating). This assessment
will also determine the participant’s level of intention,
perceived behavioural control, and attitude towards to
the adoption of the chosen behaviour.
Experimental group (EG): TAVIE en santé
TAVIE en santé is a Web-based tailored tri-component
intervention addressing smoking cessation (SC), phys-
ical activity (PA) and healthy eating (HE, e.g. with a
focus on making good choices regarding fat). Each
component (SC, PA, HE) consists of seven interactive
computer sessions lasting 5–10 min (total duration ≈
50 min per component) hosted by a virtual nurse. The
first and second sessions help the participant in identi-
fying the benefits and drawbacks to adopting the
chosen behaviour and in focusing on the benefits. The
third and fourth sessions aim for the participant to
identify barriers to adoption and ways to overcome
them. In the fifth and sixth sessions, the participant for-
mulates an action plan to adopt the behaviour. The sev-
enth session acts as a booster.
Based on the online assessment of intention, per-
ceived behavioural control, and attitude, three profiles
are generated by a computer algorithm. The number
of sessions, theory-based intervention methods and
tailored message content will vary according to the
profile. Profile 1 corresponds to participant with a
low attitude toward changing the selected behavior,
thus requiring a higher number of sessions (7 ses-
sions). Profile 2 targets participants who have a low
perceived behavioural control, which also requires a
higher number of sessions (5 sessions). Profile 3 is for
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participants who have a high intention to modify their
behaviour requiring a total of three sessions. Each
profile receives specific, theory-based intervention
methods and tailored messages. For example, belief
selection and persuasive communication are used to
change the participant’s attitude towards the behav-
iours; coping, planning and role modeling are used to
improve perceived behavioural control and goal set-
ting and implementation of intentions are used to act
upon intentions.
During each session, the virtual nurse provides posi-
tive reinforcement, and feedback on the significant ele-
ments of the previous session. This ensures follow-up
prior to each new session by verifying the participant’s
understanding of the skills proposed and their applica-
tion in daily life. Aside from delivering tailored teach-
ing, the virtual nurse also refers to the experiences of
other people who have been able to cope with similar
situations successfully.
Access to the TAVIE en santé sessions will be unlim-
ited in terms of intensity, frequency, and length of use
for the duration of the study. After having completed
their sessions, participants will have access to all previ-
ous sessions using a table of contents. TAVIE en santé
is available both in French and in English. Nearly 350
Web pages have been created that contain 296 videos,
164 animated narrations and 84 PDF files containing
information and tools. The Appendices 1 and 2 illus-
trate, respectively, a screenshot of a TAVIE en santé
intervention Web page and examples of PDF files avail-
able to participants.
Control group (CG): list of predetermined Websites
The participants in the control group will be invited to
visit five predetermined conventional health-related
Websites offering libraries of information about the be-
haviour that they chose: smoking cessation, being phys-
ically active or healthy eating. These Websites were
created by recognized Canadian agencies and associa-
tions (e.g.: Government of Canada, Canadian Cancer
Society, Lung Association, Dieticians of Canada, Heart
& Stroke Foundation, ParticipACTION). Therefore,
their contents are reliable and the informations pre-
sented are of high quality. The lists of the Websites
were validated by experts in each domain, including a
nutritionist, kinesiologist, and smoking cessation nurse
specialists.
There are two main differences between the control
group and the experimental group: tailoring and the
messenger. TAVIE en santé is a tailored intervention
hosted by a virtual nurse that follows a decision tree,
whereas the predetermined Websites offer general infor-
mation not transmitted by a messenger.
Measures/outcomes
All outcomes will be measured with a self-administered
online questionnaire hosted on a secured Web page
and will be collected at three times: baseline (t0, 46
questions), and three (t1, 26 questions) and 6 months
(t2, 34 questions) after baseline. Based on Prochaska’s
[32] work on smoking cessation, physical activity and
healthy eating, 6 months is the amount of time needed
for this sort of health behaviour change to occur.
Primary outcome measures: health behaviours
The primary outcomes are the health behaviours (smok-
ing cessation, physical activity, healthy eating). The sam-
ple will be divided into three subgroups by their choice
of health behaviour. At 6 months post-baseline, the indi-
vidual results for the chosen behaviours will be pooled
and analyzed as a composite binary outcome (0 = failure
to change the selected behavior, 1 = successful change of
the selected behavior).
Smoking cessation will be measured with a single ques-
tion: “In the past 7 days, have you had a smoke or even
just a single puff?” Compared to biochemical verification
(urinary nicotine test), this self reported-measure has a
sensitivity of 96.9 % and a specificity of 93.4 % [33] and
it correlates well with biochemical validation [34].
The level of physical activity will be measured
through the adaptation of a procedure [35] elaborated
and validated by Godin and al. [36, 37]. This measure
has proven to be relevant in the context of participation
in physical activity [38]. Participants will indicate, dur-
ing a typical week and for each level of intensity (high,
moderate, low), the frequency and the mean duration
of physical activity practice.
Diet quality will be assessed via the short question-
naire Starting the Conversation. This is an 8-item sim-
plified food frequency instrument [39] derived from a
validated 54-item instrument [40]. Four items assessed
the frequency of fat-related foods (e.g. fast food, chips,
dessert, butter or meat fat), two items relate on vege-
table/fruits, one item on sweetened beverages and one
on protein (e.g. beans, chicken, fish).
Secondary outcomes measures: cognitions
Intention, perceived behavioural control, and attitude re-
garding the adoption of the chosen health behaviours
will be measured, respectively, through 3, 3, and 5
items respectively on a 5-point bipolar scale, as recom-
mended by Ajzen and Fishbein [41, 42]. All items re-
ports to the future (“over the next 3 months”) and to
the chosen health behaviour (a: stop smoking, b: do
more physical activity, c: make better choices regarding
fat in my diet). Intention is assessed by three items: “I
intend to (a, b or c)”; 2) “I will (a, b or c)” and 3) “the
chances that I will (a, b or c) are…”. Perceived
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behavioural control is assessed by three items: 1) “I feel
that I will be able to (a, b or c)”; 2) “I am confident that
I will succeed in (a, b or c)”; 3) “How much control do
you have over (a, b or c)?” Attitude is measured by ask-
ing participants to respond–using five 5-point adjective
pairs (unpleaseant/pleasant, useless/useful, bad/good,
unsatisfying/satisfying, boring/interesting)–to the state-
ment linked to their chosen behaviour “Smoking cessa-
tion would be for me…” or “Doing more physical
activity would be for me…” or “Making better choices
regarding fat in my diet would be for me…”.
Other measures
Sociodemographic data, such as sex, age, level of educa-
tion, employment, and living situations will be assessed
at baseline. Also, health indicators will be assessed
through the self-report of HIV therapeutic regime and
includes: HIV diagnosis, HIV viral load, CD4 count,
blood pressure, blood cholesterol, diabetes, height/
weight and general health condition perception.
Recruitment
The study will be advertised in the three provinces
where most of the target population lives: Ontario,
Quebec and British Columbia. Recruitment will be
mainly done offline in medical clinics, community
agencies and community organizations working with
PLHIV: health professionals and stakeholders will be
invited to inform their clientele about this study using
traditional methods, such as posters and information
brochures. The project will also be adversited on the
Websites of resources available to PLHIV (e.g.
CATIE) where a hyperlink will be inserted to redirect
PLHIV interested in participating to the study’s
Website.
Online data collection and allocation process
The study will be conducted entirely online, the data
collection process is very similar to the one described
by Côté et al. 2012 [43]. The participant timeline, based
on SPIRIT 2013 statement [44], is illustrated in Fig. 1.
Interested partcipants will be invited to visit the
Website, which contains video clips about the study
(see Appendix 3). After accepting the conditions and
consenting, they will enroll in the study by providing
an email address and a pseudonym. Each participant
will be validated through an email address check [43].
After their enrolment via the study’s Website, partici-
pants will receive a hyperlink via email to invite them
to complete a baseline questionnaire (t0) and to choose
the behaviour that they wish to change. Only after the
questionnaire has been completed will the participants
be randomly assigned by the computer system to the
EG or the CG. Participants will then receive an email
containing the URL directing them to their intervention.
Three (t1) and 6 months (t2) after the initial measurement,
participants will complete the online questionnaires again.
Personalized reminder e-mails will automatically be
sent at 14-day intervals prior to the measurement to
encourage participants to perservere with the study.
Other personalized reminder e-mails will be sent out to
optimize participation in the interventions. Participants
will be compensated for the time spent on the study
with an Amazon.ca gift certificate of $20 after the sec-
ond and third measurement times.
Randomization
As recommended in the CONSORT-EHEALTH state-
ment, participants will be randomized only after they
have completed the baseline assessment [45]. They will
be randomly assigned to either control or experimental
group with equal probabilities (1:1 allocation ratio).
The allocation sequence has been generated by a per-
muted block randomization list. This method will en-
sure close balance of the number of participants in
each group at any time during the study.
The allocation process (concealment and implemen-
tation) will be entirely computerized. The sequence will
be programmed into the database intervention and the
participants will be informed automatically by email
about the group to which they are assigned.
Blinding
Given the differences between the two interventions
arms described in the consent form, participants will
be aware of the intervention they have been random-
ized into. However, it may be less evident to partici-
pants which group is the experimental group and
which is the control group. In order to send the ap-
propriate reminder emails, the research coordinator
will be aware of the participant’s assignment. During
data entry and analysis, the research team will be
blinded to participant’s group assignement (one data-
base will contain participants’ information and an-
other only the collected datas).
Analysis
Descriptive statistics will be used to compare the par-
ticipants in the two groups with means, medians,
standard deviations, and inter-quartile ranges for con-
tinuous and frequency distributions for categorical
and binary variables. Any variable for which the differ-
ence between the two arms is considered clinically
important will be adjusted through multivariable ana-
lyses. The principal analyses will focus on testing the
hypothesized differences between the two trial groups
using the Intention-to-Treat (ITT) analysis.
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The primary outcome of the success/failure in the
adoption of the chosen health behaviour at 6 months
will be analyzed as a binary outcome. Accordingly, the
primary hypothesis will be tested with the 2-tailed chi-
square test, with 1 degree-of-freedom (df ), at α = 0.05
significance level. Next, to adjust the intervention ef-
fect for potential confounders, we will build a multi-
variable logistic regression with adjustment for any
baseline characteristics for which the descriptive ana-
lyses indicate a clinically important difference between
the two groups. The multivariable model will also ad-
just for baseline values of the chosen health behaviour.
In the multivariable logistic regression, the effect of
the intervention will be estimated by the adjusted
Odds Ratio, with 95 % CI, and its statistical signifi-
cance will be tested by the model-based 1-df Wald
chi-square test at 2-tailed α = 0.05. During ITT ana-
lyses, all participants will be assessed in their respect-
ive randomization group as to whether they are
following the procedure or have been lost to attrition
during the follow-up. In this manner, all participants
lost to follow-up before 6 months will be assigned a
‘failure’, regardless of the group to which they were
assigned randomly. This approach is conservative be-
cause it reduces the estimated difference between the
two randomization groups.
The secondary outcomes of intention, perceived be-
havioural control, and attitude, will be evaluated at the
3-months follow-up, and analysed as continuous vari-
ables. Thus, the same analytical methods will be used
for all these outcomes. The distribution of the out-
come scores will be assessed for normality of residuals
using the Shapiro-Wilk test. We will assign the indi-
vidual baseline score for a given outcome to partici-
pants who fail to provide data for a given outcome. To
test the statistical significance of the un-adjusted dif-
ference between the mean values of a given (possibly
transformed) outcome observed in the two trial arms
at 3 months, we will use the 2-tailed independent-
groups student’s t-test at α = 0.01. Multivariable linear
Fig. 1 Schedule of enrolment, interventions, and assessments
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regression will be used to adjust the estimation and
testing of the intervention effect for potential con-
founders, for which the descriptive analyses indicate a
clinically important difference between the two
groups. In multivariable linear regression, the effect of
the intervention will be estimated by the adjusted
mean difference, with 95 % CI, and its statistical sig-
nificance will be tested by the model-based F-test with
1-df in the numerator, at 2-tailed (Bonferoni-cor-
rected) α = 0.01.
Ethics
Research ethics approval
In Quebec, this research protocol has been approved by
the Research Ethics Board (REB) of the Centre Hospita-
lier de l’Université de Montréal (CHUM) following a
multicentre research project protocol. The CHUM REB’s
approval will then be forwarded to the other local study
sites in Ontario and British Columbia, which will then
seek the approval of their respective boards.
Consent
Due to the online nature of this study, the informed
consent will be obtained online. To pique the inter-
est of potential participants and render the study’s
Website more dynamic and interactive, video clips
will be posted, containing information about the
study. In one of them, a peer will present specific in-
formation about the study (goal, modalities of par-
ticipation, eligibility criteria, confidentiality, financing,
etc.). Consent to participate will be presented in the
form of a statement to be read and approved by
clicking on a button “I agree to participante” [43]. A
“Withdraw” page will always be available so that par-
ticipants have the freedom to withdraw from the
study at any time.
Confidentiality
The data collected online will be stored on a secure ser-
ver located at the Research Centre of the CHUM and
accessible to the research coordinator and principal in-
vestigator only. To protect the participants’ identity, an
e-mail address and a login name known only to the re-
search coordinator and the system administrator will be
requested of participants. This information is necessary
to ensure follow-up while respecting confidentiality, as
pointed out by Michalak and Szabo [46]. Firewalls, data
encryption, password protection, and separation of
socio-demographic data from experimental data will re-
duce the risk of unauthorized access to confidential
content by a third party [47, 48].
Results
Study Website description
A Website was created to promote and conduct this online
study (see Appendix 3). As suggested by Hershberger and
Coll. (2011), this Website was designed to communicate in-
formation, establish credibility, and facilitate contact [49].
Videos, animation, text, and PDF files are used to de-
scribe the purpose and implications of the study to the
participants. All materials were prepared with ease of
comprehension in mind. To inform participants about
the partners of the study, we created a page to display
the logos of the University’s affiliations of the investiga-
tors, financing organizations and recruiting sites. To fa-
cilitate communication, a “Contact Us” navigation tab,
containing information on technical support or the
reaching the research coordinator, is visible in every
page of the Website.
Study flow diagram
Once participants enrol in the study, they will follow dif-
ferent “pathways” over the 6 months of the study. The
pathways depend on the chosen language and behaviour.
During the enrolment process, participants will choose
the language they prefer (French or English). The behav-
iour they choose in the baseline questionnaire (smoking
cessation (SC), being physically active (PA), following a
healthy eating (HE)) will impact randomization and
follow-up questionnaires (t1 and t2). Therefore, there will
be six pathways, as illustrated in Fig. 2.
Discussion
Challenges and sources of bias
The study will be conducted entirely online, which poses
various challenges in terms of participants’ selection and
data collection [50]. One of our earlier online studies
established the feasibility of the proposed research meth-
odology and will serve as a guide to participants’ selec-
tion and data collection [43]. For instance, to prevent
participants from registering more than once, the com-
puter system will screen them to verify whether they
meet the eligibility criteria. The design of the online
questionnaire will only allow answering one question at
a time and will not allow backtracking.
The study design will be controlled as best as pos-
sible but participants will not be totally blinded to
group assignment. The CG will receive a detailed list
of Websites providing relevant information related to
health behaviour and available resources and services.
Group equivalence will be ensured through random
assignment and–if necessary–statistical adjustments,
through multivariable regression modeling, for any
potential imbalance in the distribution of any relevant
baseline characteristic will be performed. Measures
will be taken to ensure intervention fidelity/consistency by
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documenting all aspects of the intervention. Moreover,
the intervention’s parameters will be recorded (number of
pages visited), thus making it possible to obtain a reliable
picture of the actual intervention intensity: duration and
frequency of the intervention.
To reduce contamination bias, participants will be
sensitized to the importance, from a research viewpoint,
of not sharing with others the intervention material to
which they will have access during the study. In any
event, given that one of the particularities of the
Fig. 2 Study flow diagram
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intervention is that it is “tailored”, the personalized feed-
back and information received is unlikely to be relevant
to another participant. A selection bias will be inevitable
because participants invited to participate in the study
must necessarily have Internet access [51]. Given that
the size and demographic characteristics of the online
population are different from those of the off-line
population [52–54], the results of the study will not be
generalizable to PLHIV as a whole [55]. Given that
many PLHIV are living on fixed incomes and for whom
personal internet access may not be available, this con-
stitutes a limitation of the planned intervention; how-
ever, for those who are able and willing to use
technology, TAVIE en santé provides a potential health
promoting and reinforcing resource.
Projected impacts, benefits, and transfer of the study
Until now, most of the studies testing the efficacy of
Web-based tailored health behaviour change interven-
tions have been designed and conducted among the
general population, were more preventive in nature and
did not involve support for complex tasks required in
self-management of chronic conditions (Lustria et al.,
2013). According to Murray (2012), Web-based inter-
ventions for people with long-term conditions remain a
challenge and may be less successful. The aim of the
study is to evaluate an innovative Web-based tailored
intervention for encouraging PLHIV to adopt specific
health behaviours. This study will yield new results
about the efficacy of Web-based tailored health be-
haviours change interventions in the context of
chronic diseases (chronically ill patients).
Given the current short supply of specialists in
healthcare and in the area of HIV-related services,
TAVIE en santé offers clinicians an complementary in-
strument to support their professional practice and
meet their clientele’s needs with a minimum invest-
ment. As it consists essentially of simulated interactions
between a virtual nurse and the PLHIV, all that is
needed is to provide minimal remote computer support
services available in case of technical problems. This
computer innovation affords the system administrator
the flexibility to add and modify page without always
having to resort to a Web developer. Thus, it reduces
the costs of the system and facilitates the implementa-
tion of solutions over the long term in a normal context
of clinical practice.
Appendix 1
TAVIE en santé screenshot.
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Appendix 2
Examples of TAVIE en santé PDF tool for participants.
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Appendix 3
Study website screenshot.
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